Anti-ZnT8 autoantibodies: A new marker to be screened in patients with anti-adrenal antibodies
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 511, 1-6
Abstract
No abstract availableKeywords
Funding Information
- Hospices Civils de Lyon
This publication has 33 references indexed in Scilit:
- Novel Diabetes Autoantibodies and Prediction of Type 1 DiabetesCurrent Diabetes Reports, 2013
- Molecular Architecture and Function of ZnT Transporters2012
- ZnT8 and type 1 diabetes [Review]Endocrine Journal, 2012
- Diabetes Antibody Standardization Program: First Proficiency Evaluation of Assays for Autoantibodies to Zinc Transporter 8Clinical Chemistry, 2011
- Autoimmune Addison’s Disease2010
- Zinc Transporter 8 Antibodies Complement GAD and IA-2 Antibodies in the Identification and Characterization of Adult-Onset Autoimmune DiabetesDiabetes Care, 2009
- Diabetes-linked zinc transporter ZnT8 is a homodimeric protein expressed by distinct rodent endocrine cell types in the pancreas and other glandsNutrition, Metabolism and Cardiovascular Diseases, 2009
- SlC30A8 Is a Major Target of Humoral Autoimmunity in Type 1 Diabetes and a Predictive Marker in PrediabetesAnnals of the New York Academy of Sciences, 2008
- The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetesProceedings of the National Academy of Sciences, 2007
- 21-hydroxylase, a major autoantigen in idiopathic Addison's diseaseThe Lancet, 1992